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The Mid-Atlantic Ethics Committee

Newsletter is a publication of the
Maryland Health Care Ethics
Committee Network, an initiative
of the University of Maryland
Francis King Carey School of Law’s
Law & Health Care Program. The
Newsletter combines educational
articles with timely information
about bioethics activities. Each issue
includes a feature article, a Calendar
of upcoming events, and a case
presentation and commentary by local
experts in bioethics, law, medicine,
nursing, or related disciplines.
Diane E. Hoffmann, JD, MS
Editor

CODE OF ETHICS & QUALITY
ATTESTATION FOR ETHICS CONSULTANTS
In 1998, the American Society for Bioethics and Humanities (ASBH) published
the first edition of the Core Competencies for Health Care Ethics Consultation.
The Task Force for Standards on Bioethics Consultation recommended that the
Core Competencies be used as voluntary
guidelines, and discouraged movement
toward “professionalizing” ethics consultants (for example, through individual
certification and program accreditation).
However, the field of ethics consultation
continues to evolve, with several postgraduate programs and clinical fellowships available to educate and train ethics
consultants. In 2011, ASBH published
the second edition of the Core Competencies, in which the movement toward
professionalizing the field of health care
ethics (HCE) consultation was recognized, rather than discouraged. A small
but growing number of HCE consultants
have advocated for moving their field
forward by developing a Code of Ethics,
certification of ethics consultants, and
accreditation of programs that train ethics
consultants.
ASBH has responded. Its Clinical Ethics Consultation Affairs (CECA) Standing Committee is developing a Code of
Ethics for Health Care Ethics Consultants
(see Box). ASBH is currently collaborating with Eric Kodish, a physician and
ethics consultant at the Cleveland Clinic,
who was recently awarded a grant from
the Josiah Macy, Jr. Foundation to support a project entitled, “Toward Consen-
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sus: Quality Attestation for Clinical Ethics Consultants.” ASBH’s position is that
all individuals who do HCE consultation
should be held accountable to the standards outlined in the Core Competencies.
However, only individuals functioning
at an advanced level—particularly those
doing solo HCE consultations—would
pursue the “Quality Attestation,” which
would be a step toward a more formal
certification process in the future.
Members of the Core Competencies
Update Task Force (which authored the
second edition of the Core Competencies) recognize that most individuals
doing HCE consultation do not consider
themselves to be professional HCE
consultants. However, the Task Force
believes that running an effective ethics
consultation service typically requires
having access to at least one individual
with advanced-level HCE consultation
competency. Toward that end, efforts toward professionalizing HCE consultants
will hopefully not displace health care
providers who wish to remain involved
in ethics activities at their institutions,
but instead, will ensure that there are
enough expert HCE consultants to help
run ethics programs at health care organizations throughout the country. The
goal is that this should make it easier,
not harder, for those who want to stay
involved in HCE consultation activities at their institutions to do so without
feeling overburdened. But this will
Cont. on page 2
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Code of Ethics
Cont. from page 1
only happen if health care administrators and corporate leaders realize the
value of having an ethics consultant
with recognized expertise in charge of
their health care organization’s ethics
program. Below is the Draft Code of
Ethics for Health Care Ethics Consultants prepared by the ASBH Clinical
Ethics Consultation Affairs Standing
Committee.
Draft Code of Ethics for Health
Care Ethics Consultants
Preface: This statement sets out the
core ethical responsibilities of anyone
engaged in health care ethics (HCE)
consultation. HCE consultation is ‘a
set of services provided by an individual or group in response to questions
from patients, families, surrogates,
health care professionals, or other
involved parties who seek to resolve
uncertainty or conflict regarding valueladen concerns that emerge in health
care’ (ASBH CC TF, 2011). The goals
of HCE consultation include identifying, clarifying and analyzing the
ethical issues that underlie the consultation request. HCE consultation seeks
to facilitate agreement among involved
parties about ethically justifiable options. HCE consultation addresses the
ethical concerns of persons involved
in health care decision making and
medical research, including patients,
families, and providers, and those who
set guidelines and create policies.
In addition to their role as HCE

consultants, some individuals are also
members of other professions and may
be accountable to different codes of
ethics. While engaging in HCE consultation, individuals should adhere to
this statement of responsibilities.
Professional Responsibilities
Be competent: HCE consultants
should practice in a manner consistent
with recognized standards of excellence.
Avoid conflicts of interest: HCE
consultants have an obligation to properly manage conflicts of interest, i.e.,
situations in which the professional
judgment of a HCE consultant may
appear to be affected or compromised
by a personal or financial interest, especially in a way that might adversely
affect recommendations regarding patient care. If it is not possible to avoid
a conflict of interest through recusal or
referral, HCE consultants have an obligation to be transparent and make full
disclosure to all the involved parties
of the nature of the conflict, maintain
their independence, remain unbiased,
and to exercise good professional
judgment.
Avoid conflicts of obligation: HCE
consultants should identify, disclose,
strive to avoid and manage within
ethically appropriate means those
conflicting obligations that arise when
they perform multiple roles within an
organization. Consultants may need

Be a part of the process! Provide your thoughts and comments to
drafters of the Code at a special workshop at the ASBH Annual
Meeting on Friday, October 19, 1-2:30 PM, at the Hyatt Regency
on Capital Hill in Washington D.C. The ASBH Annual Meeting
"Representing Bioethics" offers pre-conference sessions, concurrent and plenary sessions from October 18-21. It alternates cities
so take advantage of its proximity and consider attending this
year! See http://www.asbh.org to view the full program.

to recuse themselves when conflicts
of obligation cannot be appropriately
managed.
Protect confidentiality: HCE
consultants should recognize when
information is personal, respecting and
protecting privacy with confidentiality, and only sharing such information
with discretion in accordance with
standards of ethics, law, and organizational policy.

Promote integrity: HCE consultants should cultivate attitudes and attributes that support reflective practice
and promote personal and professional
integrity.
Make responsible public statements: When addressing the lay public about HCE issues, HCE consultants
should speak responsibly.

advancement of the field through
contributions to practice, education,
administration, knowledge, and/or
skill development.
Promote just health care: HCE
consultants should collaborate with
other professionals and lay persons to
promote a more equitable health care
system.

Contribute to the field: HCE
consultants should participate in the

MHECN CO-SPONSORS COMMUNICATIONS CONFERENCE
WITH CARROLL HOSPITAL CENTER
On June 13, 2012, MHECN collaborated with Carroll Hospital Center
to hold a workshop entitled, “Navigating Communication Landmines in
Ethics Consultation.” The workshop
was co-developed by Lucia Wocial,
Ph.D., R.N., Nurse Ethicist with The
Fairbanks Center for Medical Ethics
(FCME) at Indiana University Health
and Sandra Petronio, Ph.D., Professor
in the Department of Communication
Studies, senior affiliate faculty with
FCME, and Core Faculty of the Indiana University Center for Bioethics.
Dr. Wocial presented at the workshop, incorporating concepts adapted
from the work of Drs. Ann Cook and
Helena Hoas, who direct the National
Rural Bioethics Project at the University of Montana (http://www.umt.edu/
bioethics/ ). Cook and Hoas discovered that health care providers in rural
settings were not troubled as much by
“ethical problems” and dilemmas often featured by academic bioethicists.
Rather, they were troubled by conflicts
arising when health care providers
from different disciplines disagreed
with each other when trying to make
health care decisions. Wocial adapted
a script from the National Rural
Bioethics Project’s Reader’s Theater,
in which characters play out a scene
demonstrating various communication
landmines.

The workshop focused on the
following ethics consultation skills
identified in the Core Competencies
for Health Care Ethics Consultation
(ASBH, 2011):
•

Listen well, communicate interest, respect, support and empathy to involved parties.

•

Enable the involved parties to
communicate effectively and be
heard by other parties.
•

Recognize and attend to various relational barriers to communication.

Anyone who has done ethics consultation knows that communication
breakdown is at the root of many, if
not most, ethics consultation requests.
This likely stems from a definitional
feature of communication that Dr.
Wocial underscored in her introductory presentation: communication is
the response you get from the message
you send regardless of your intent. Dr.
Wocial reviewed the following five
core communications competencies:
•

Communicative Adaptability:
Remaining composed during
communication interactions
and responding appropriately
through confirmatory statements
based on others’ perceptions and

understanding of the situation
(e.g., “You did the right thing by
asking for help.”).
•

Conversational Involvement:
Being responsive, perceptive,
and attentive to what others in
the encounter are communicating, without minimizing what
they feel is important, while
paying attention to meta-messages (e.g., “I can see you’re
angry that your blood had to be
redrawn.”).

•

Conversational Management:
Taking appropriate turns when
speaking and avoiding unnecessary interruptions, asking
meaningful questions, and being
attentive to non-verbal messages
(e.g., “You say that you’re not
angry but you seem upset to me.
Are you upset? … Can you tell
me more about that?”).

•

Empathy: Listening attentively
and reacting to the person’s
emotional state, offering tissues if the person is crying,
not changing the topic merely
to reduce emotional intensity,
showing warmth and caring via
verbal and non-verbal messages
(e.g., “Oh my, you’ve been
Cont. on page 4
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Conference
Cont. from page 3
through so much this last month.
I’m so sorry.”).
•

Respect and Expectations: Paying attention to those involved
in the communication encounter and respecting different
points of view. Looking for the
meta-communication issues to
identify the way individuals
involved are framing the issues
and taking them into account.

Workshop attendees then reviewed
specific “communication landmines”
that can derail an effective ethics
consultation (as well as other communication encounters). These include
“negative messaging” that makes people involved feel unimportant, disrespected, undervalued, or insignificant.
For example, implicit or explicit statements may dismiss or discount another
person’s credibility or point of view.
Other examples of “negative messaging” include defensive behaviors
(e.g., being judgmental, controlling,
unemotional, or inflexible), relational
barriers (e.g., jumping to conclusions,
being hostile), and listening barriers
(e.g., avoiding difficult topics, being
closed-minded, bored, inattentive, or
insincere).
The ethics consultant should obviously avoid displaying these negative
messages, but more commonly, should
recognize them and respond when
others involved in an ethics consultation exhibit negative messaging during
the consultation process. Strategies
involve disarming these communication landmines by counteracting the
negative messaging with “confirming”
messaging. For example, say during
an ethics consultation group meeting,
the patient’s adult daughter says, “My
brother (Joe) doesn’t care about my
mom. He never comes to see her.” The
ethics consultant could disarm such a
remark through a confirming message,
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such as, “Joe
is here with us
now. Let’s hear
what he has to
say.”
Disarming
defensive behaviors during ethics
consultation can
be challenging,
as these often
arise from underlying emotional turmoil of
the individuals
involved. It’s
(from l to r:) Anita Tarzian, PhD, RN, MHECN Program Coorimportant to be
dinator; chaplain Angela Boggs, Manager of the Spiritual Care
astutely aware of Department at CHC; Diane Hoffmann, MHECN Executive Direcyour own bodily tor and Professor of Law at the University of Maryland School of
Law; Lucia Wocial, PhD, RN, nurse ethicist at Indiana University
responses, as
strong emotions Health Charles Warren Fairbanks Center for Medical Ethics; and
Kevin Smothers, M.D., F.A.C.E.P., Senior Vice Presient of Medical
cause physiAffairs and Chief Medical and Quality Officer at CHC.
ologic changes
that affect one’s
parties, and another involving a group
vocal tone, posture, facial expressions, meeting with involved parties. The
hand gestures, etc. The aim here is for involved parties included: the patient’s
“bounded emotionality” - that is, acprimary physician, ER physician,
knowledging emotions that come up,
primary nurse, social worker, chaplain,
expressing them constructively (e.g.,
adult daughter, and adult son. Work“You seem sad” … “I feel frustrated
shop attendees tried to spot the landwhen you …”), and at the same time,
mines and took turns trying to disarm
exercising control over them. Disarm- them with the strategies Dr. Wocial
ing relational and listening barriers
presented. Attendees were enthusiinvolves various strategies to gain
astic about this interactive method of
trust and connect with individuals in
practicing advanced communication
the communication encounter.
skills.
Most health care professionals have
If you are interested in using the
received some education or training
workshop case study and script for a
on effective communication strategies. training session at your facility, conYet, there are too few opportunities
tact Anita Tarzian at (410) 706-1126,
to hone these skills, particularly as
atarzian@law.umaryland.edu.
they relate to ethics consultation. At
the workshop, volunteer actors read
through two scripted scenes based on
a case study involving a 72 year old
hospitalized woman at the center of
an ethics consultation: one involving
one-on-one conversations between the
ethics consultant and various involved

DHMH RESPONDS TO MOLST FEEDBACK
Maryland Medical Orders for Life
Sustaining Treatment (MOLST) is a
portable and enduring form for orders
about cardiopulmonary resuscitation
and other life-sustaining treatments.
MOLST regulations were proposed
in the September 23, 2011 Maryland
Register, with the public comment
period ending October 24, 2011. The
Department of Health and Mental
Hygiene (DHMH) summarized the
comments they received in the August
10, 2012 issue of the Maryland Register. These comments and responses are
excerpted from The Maryland Register, 39(16), August 10, 2012, 1087-89.
Comment: Several comments
emphasized the value of patient
decision making in health care
and urged DHMH to issue regulations to implement MOLST.
Response: DHMH is proposing
these regulations to implement
MOLST and support patient autonomy in key health care decisions.
Because DHMH highly values the
input of affected organizations
and individuals, the Department
accepted public comment on the
initial proposal. DHMH is accepting
public comments on this proposal as
well.
Comment: Several comments
recommended providing time for
training and preparation prior to
implementation of the MOLST
regulation.
Response: DHMH agrees with this
comment. The final MOLST regulation will provide time for training
and preparation.
Comment: Several comments
expressed concern that under certain circumstances, the MOLST
is inappropriate and could affect
the trust between the provider
and the patient. Specifically, comments recommended that MOLST
should not be required for patients whose primary diagnosis is

related to pregnancy, children under age 18 with non-life threatening conditions, and patients with a
primary psychiatric diagnosis.
Response: The proposed regulations
exempt these three populations from
the requirement that their physicians
fill out a MOLST form. Physicians
caring for these patients may elect
to fill out a MOLST form, depending
on the circumstances and the voluntary participation of the patient.
In addition, the training for MOLST
includes education for health care
providers about discussing lifesustaining treatment decisions with
a patient or authorized decision
maker.
Comment: A comment noted that
the completion of a MOLST form
should always be based on voluntary participation from the patient
or the patient‘s authorized decision maker.
Response: DHMH agrees with the
comment. The proposed MOLST
form already includes the following
language:
“Mark this line if the patient or
authorized decision maker declines
to discuss or is unable to make a
decision about these treatments.
The patient‘s or authorized decision
maker‘s participation in the preparation of the MOLST form is always
voluntary. If the patient or authorized decision maker has not limited
care, except as otherwise provided
by law, CPR will be attempted and
other treatments will be given.”
Comment: Several comments
expressed concern about the language on the form related to medical effectiveness and the Health
Care Decisions Act. This legal
path is rare in Maryland and must
be substantiated with appropriate
documentation.
Response: DHMH recognizes that
medical ineffectiveness is a rarely

used path in Maryland. Based on
the comments, the proposed regulation rewords the language related to
the Health Care Decisions Act and
makes reference to the requirement
for appropriate documentation in
the medical record. The proposal,
however, does not drop all mention of the Health Care Decisions
Act from the MOLST form, on the
grounds that (1) Existing EMS
forms provide an option to document an order based on this path,
and MOLST should be consistent
with current practice and (2) the
MOLST legislation anticipates that
the MOLST form can serve as a
single pathway for orders regarding
life-sustaining treatments.
Comment: A comment stated that
to be consistent with the Health
General Article, the MOLST
regulation should state consistently that a health care facility
shall, “On request of the patient,
offer any physician or nurse practitioner selected by the patients
the opportunity to participate in
updating or completing the form.”
Response: DHMH agrees. The proposed regulation states:
E. When initially completing a
MOLST form or updating an existing MOLST form, a health care
facility shall:
(1) Offer the patient or authorized
decision maker the opportunity to
participate in completing or updating the MOLST form, and on request
of the patient, offer any physician
or nurse practitioner selected by the
patient the opportunity to participate in updating or completing the
MOLST form.
In addition to the above changes,
the proposed regulation corrects the
website address, clarifies a statement related to maintenance of the
Cont. on page 6
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MOLST form in the patient‘s active
medical record, deletes the phrase
“Blank order forms shall not be
signed,” as it is standard not to sign
blank order forms, and makes several clarifications under the section
“certification for the basis of these
orders.”

Comments sent to Michele A. Phinney, Director, Office of Regulation and
Policy Coordination, Department of
Health and Mental Hygiene, were accepted through September 10, 2012 . A
public hearing has not been scheduled.
This issue of the Maryland Register
is available at http://www.dsd.state.
md.us/MDRegister/3916.pdf .

For updates on the MOLST form
and to download the form itself, visit
http://marylandmolst.org/

CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY INVOLVING A
POSSIBLY PREGNANT DONOR
A 27 year old woman involved in
a motor vehicle accident is declared
dead by neurologic criteria. She had
indicated on her driver's license that
she wished to be an organ donor, and
her parents have agreed (she is unmarried). As the transplant surgeon proceeds with the surgery to procure her
organs, he suspects from the size and
feel of her uterus that she may be pregnant. He asks staff to check whether a
pregnancy test was done in the emergency department or intensive care
unit; there is no record of a pregnancy
test in her medical records. He asks a
nurse to do a pregnancy test. The nurse
wonders whether consent to test for
pregnancy is required. They decide to
call the ethics consultant on call to ask
whether they need to get consent to do
a pregnancy test.
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COMMENTARY FROM A
TRANSPLANT ETHICIST,
TRANSPLANT SURGEON,
AND ORGAN PROCUREMENT
ORGANIZATION MEDICAL
DIRECTOR
In this case, we have a 27 year-old
female, who has been declared dead
by neurologic criteria (i.e., “brain
dead”). She has previously authorized
donation of her organs by so designating on her driver’s license. This is a
document of gift under the Maryland
Revised Uniform Anatomical Gift
Act (SB756, 2011), and although, as
stated, her parents have agreed, the decedent’s authorization is sufficient and
binding in and of itself (see http://mlis.
state.md.us/2011rs/billfile/sb0756.
htm).
As organ recovery begins, “the
surgeon suspects from the size and feel
of the uterus that she might be pregnant.” No pregnancy test has yet been
performed, and when the surgeon asks

that one be done, a nurse questions
whether consent needs to be obtained
for this, and an emergent ethics consult is requested. The question initially
posed to the clinical ethicist is whether
consent is required to perform a pregnancy test on this donor, but to answer
this question, we need much more
background information regarding authorization (note that I do not use the
word “consent”) for donation, and also
about the outcomes of pregnancies in
brain dead individuals. Thus, if it were
known that no brain dead individual
had ever been artificially maintained
(not “kept alive!”) long enough to deliver a live infant, then the question of
pregnancy becomes moot. It is entirely
possible that this knowledge base is
not within the experience of a single
individual, and so even if the ethics
consult in such an emergency may be
responded to by a single person, (s)he
may need to reach out to others with
the expertise necessary to provide the

factual base required for meaningful
recommendations.
The question in this particular case is
unusual in the sense that it is posed
when the donor is already in the operating room, and, presumably, during
the initial exploration of the abdominal
cavity, which is routinely performed to
exclude unsuspected medical problems
that might preclude organ recovery,
such as an undiagnosed malignancy.
This suggests that, if pregnant, the
donor is relatively early in her pregnancy, as the uterus typically is large
enough to be felt on examination after
twelve weeks, and reaches the level of
the umbilicus by 20 weeks. There is
variability across the country regarding routine pregnancy testing of organ
donors, and many organ procurement
organizations (OPO) only obtain such
testing in unusual circumstances, or to
rule out particular malignancies. Obviously, it would have been preferable
for many reasons, not least of which is
the ability for a less rushed ethics consultation, to have determined whether
the donor was pregnant or not prior to
the start of the donor operation. Brain
dead individuals have been artificially
supported for as long as 3.5 months
to permit live birth of an infant, and
pregnancies have resulted in live births
from brain-dead individuals as early as
16 weeks of gestation, so the question
here is not irrelevant (Esmaeilzadeh,
2010). Although organ recovery has
begun, no irretrievable steps take place
in the procedure until the very end,
so, should the donor turn out to be
pregnant, and should the decision be
made to attempt to support the pregnancy, it would be possible to close
the incisions and return the donor to
the ICU. This would only be possible
in the case of a heart-beating, brain
dead organ donor. In the setting of
DCD donation (donation after circulatory death), no incision is made until
after the cardiopulmonary death of the
donor (and a suitable 2-5 minute waiting period thereafter), and by the time
the surgeon felt the uterus, the fetus

would no longer be viable. Similarly,
in the instance of a brain-dead donor, if the question of pregnancy was
raised after cross-clamp and perfusion
of the donor, there would be no option
of “rescuing” the fetus.
Authorization for organ donation
includes all testing necessary to determine if the subject would be a suitable
donor, and, thus, no separate consent
for a pregnancy test would be necessary. More important, however, is the
question of what one would do with
the results of such testing, and what
the ethics consultant would recommend. Obviously, a negative pregnancy test would resolve the issue, but
one should not order the test hoping
for such a result until thinking through
the course should the opposite result
be obtained. Assuming a positive test,
and assuming a pregnancy could possibly be carried until the fetus was viable, a number of important questions
face the ethicist. A non-exhaustive list
of such questions might include:
1. Did the patient know she was
pregnant?
2. If so, had she made a decision
regarding her desired outcome
of the pregnancy?
3. If the patient had planned to
keep the pregnancy, would she
make the same decision knowing she would not survive to
raise the child?
4. We know she is unmarried, but
is the putative father in the picture? Does he have an opinion,
and does he have any rights?
5. If the parents and the father
disagree, who prevails?
6. If the decision is made to try to
maintain the pregnancy, does
that preclude subsequent organ
donation? (not necessarily)
There is rarely an issue in pausing the process of organ recovery in
a brain dead donor for a few hours,
except in the case of a hemodynamically unstable donor, in which case
the issue of maintaining the pregnancy

would be out of the question anyway.
As soon as the surgeon raises the
question, a halt should be called to
the procedure until the ethics consult
can be performed. Ideally, the ethicist
should respond to the operating room,
but a phone consultation would also
be possible. The OPO medical director and administrator on-call should be
notified by the organ recovery team,
and should participate in the discussion. The clinical ethicist should also
gather whatever experts are needed
to help answer the medical questions,
whether these be members of the
hospital ethics committee, should such
expertise reside there, or others (e.g.,
maternal-fetal medicine) as necessary.
The ethicist must determine who is/
are the legal agents for the donor, and
who will make the ultimate decision
regarding the disposition of the pregnancy, should that turn out to be the
issue. Hospital counsel should also be
notified.
The ethicist, in this case, realistically
has only 3-4 hours to complete these
tasks. Had the donor been identified
as pregnant prior to beginning the
donation process, one might have days
to more leisurely consider the options
and ramifications. The ethicist should
place a preliminary note in the chart,
and a more complete note could be
submitted, both to the hospital chart
and to the OPO via the medical director, at a subsequent time.
Michael E. Shapiro, MD, FACS
Director, Surgical Education
Department of Surgery
Hackensack University
Medical Center
Associate Professor of Surgery
New Jersey Medical School/UMDNJ
REFERENCES:
Esmaeilzadeh M, et al. (2010). One life
ends, another begins: Management of a
brain-dead pregnant mother-A systematic review. BMC Med. 2010; 8:74-84.

Cont. on page 8
Mid-Atlantic Ethics Committee Newsletter 7

Case Presentation
Cont. from page 7
COMMENTARY FROM A
TRANSPLANT ETHICIST IN
AUSTRALIA
My first reaction when reading this
case was, “Why wasn’t a pregnancy
test performed before the surgeon
opened the patient for organ procurement?” [The case states: “As the
transplant surgeon proceeds with the
surgery to procure her organs, he
suspects from the size and feel of her
uterus that she may be pregnant.”] It
is unclear if the heart and lungs have
been removed, and now the abdominal
team is proceeding into that cavity for
the liver and other organs, then noticing, “the size and feel of the uterus”
being abnormal. Another possibility is
that the surgeon has opened the woman’s body and done an initial manual
exploration of all the organs and then
notices (before removing anything) the
abnormal size and feel of the uterus.
The ethicist would need to ask appropriate questions to determine the staging of the procurement procedure.
Moving from those questions, I am
troubled that the surgeon is already
inside the patient. From an ethics
perspective, the surgeon should not
have ‘proceeded to surgery’ without
knowing (by lab testing) if the patient
was pregnant or not. The standard
practice in my experience is for the organ procurement organization (OPO)
to obtain this laboratory result before
surgical recovery is initiated (Council
of Europe, 2009; Gift of Life Donor
Program, 2009; United Network for
Organ Sharing, 2004). Granted, however, “standard practice” varies according to the location of practice and
this commentary includes reflection on
regional/national regulations (Council of Europe, 2009; UK Transplant,
2011). )] The surgeon then reviews all
assay data before the donor candidate
is surgically opened in the O.R.
But, as the ethicist receiving the
consult request in the face of a surgeon
8 Mid-Atlantic Ethics Committee Newsletter

whose hands are inside the patient,
both the surgeon and I are watching
the time-clock ticking. Delays can
cause irreversible organ damage putting graft utility at risk [it is unclear
from the case details if cross-clamp
has occurred]. Because pregnancy
testing is the standard of care [in
European countries], and the woman
had registered her consent to donate,
it can be argued that her consent for
testing pertaining to donation candidacy/screening is implied. This said,
no family consent for testing would be
required and attempts to obtain such
would unnecessarily delay proceedings.
My advice in this case would be to
proceed with STAT pregnancy testing
as this assay (β-HCG) is a routine element of donor screening. With regard
to results…Because the donor candidate is already declared brain dead
and opened in the O.R. for procurement, one has to ponder if there is a
chance of fetal viability if the woman
were to be closed (assuming the heart
and lungs had not been removed) and
continued on life-support (so as to host
the fetus until term or near-term). The
question should be posed and officially
answered for the consult report. But
even if the heart and lungs had been
removed, β-HCG testing should still
be performed. Why you ask?
β-HCG testing is also pertinent to
matters of oncology, not just pregnancy. Specifically, this assay also can
act as a tumor marker in some types of
cancer, including ovarian, liver, stomach, and lung cancers. So just because
this test was missed at case onset, and
the woman is likely not able to bear a
pregnancy to term under the current
conditions, the assay may have value
in that it could yield data that indicates
she should not be a donor (if she has
a malignancy) (Council of Europe,
2009). This is an important topic for
the ethicist to include in the consult

report because it pertains to the matter
of preventing harm to future patients
(through preventing disease transmission).
[NOTE: if pregnancy was confirmed
after her heart and lungs had been
removed (one of the case stagings proposed) then there is potential legal risk
for the OPO in their failure to rule out
pregnancy before organ procurement
was initiated. See further discussion
below about brain-dead women carrying fetuses to term on life support.
The ethicist should consult a medical
malpractice attorney for information
on fetal duties and fetal harm – is the
fetus a “patient”? Is this a medical error to the deceased, a non-patient? An
error to the fetus? What legal obligations are there for the OPO?]
Responding to the O.R. the ethicist
should write a preliminary consult
note in the OPO donor chart; but if not
feasible, the guidance can be called to
the O.R. telephonically. A full consult
report should be given to the surgeon
who requested the consult asap. This
surgeon is also likely employed by
the OPO and thus it would be prudent
for the medical director of the OPO
to also receive a copy of the report.
(Note: as a matter of collegiality, the
medical director should also be notified of the consult request, though
they are already likely aware of the
matter per their own procedural rules).
It is important for the OPO medical
director to receive a copy of the ethics
consult report because this individual
needs to be aware of procedural missteps so that case review and corrective action is undertaken on an organizational level. Additionally, as an aid
to the surgeon and OPO, the ethicist
should include bioethics and regulatory references as appropriate. These
can be a great teaching tool, as well as
a source of integrity for advice given
in the report.
As an aside, if organ procurement

had not already been started; that is,
the woman was still on life support
and her body had not been surgically
opened, the case might take a different turn. β-HCG testing would still be
performed as standard procedure for
donor screening (again, depending on
regional practice variations), and positive results would then be reviewed
with the patient’s surrogate to explore
the woman’s values about pregnancy
and motherhood. Did the woman
know she was pregnant? Perhaps

she did but her family or unmarried
partner did not know. Did the woman
desire to continue her pregnancy?
Perhaps she was still deciding about
this matter? Perhaps she decided to
terminate the pregnancy but had not
yet done so. Perhaps she would have
wanted to carry the child to term? If
the latter, and there is family willing
to raise and support the child, continuing the mother on life-support with
the intent to deliver the child could be
posed (the ethicist should not exclude

the possibility that though unmarried, the woman might have been in
a long-term relationship with a man
or a woman and not married to her
partner). The psychosocial issues
would need deep exploration and the
assistance of a social worker would
be of great aid to the ethics consultation. According to Esmaeilzadeh et
al. (2010), “The important question
is from which gestational age onward
should the pregnancy be supported?
At present, it seems that there is no

WHAT, AND WHERE, TO DOCUMENT?
In the second edition of the Core Competencies for Health Care Ethics Consultation (ASBH CC TF, 2011),
“emerging process standards” were added to identify best practices for ethics consultation. The Task Force that
updated the Core Competencies recognized that ethics consultants may respond to a range of requests, but a
request involving an active patient is given special status due to the more direct potential to help or harm stakeholders based on the consultant’s involvement. For ethics consultations involving an active patient, the attending
physician and patient (or family) should be notified about the consultation, and the consultation should be documented in the patient’s medical record, in addition to the ethics consultation service’s internal records.
Dubler and colleagues (2009, p. 26) wrote: “A formal note in the medical record, such as a typed note in the
chart, is the standard method care providers use to communicate about all aspects of the patient’s care.” Should
the ethics consultation featured in this case study be documented in the patient’s medical record? Should the
patient’s family be notified about the consultation? One might argue that because the patient is dead, there should
be no family notification of the consultation nor documentation in the medical record. Recommendations at this
point do not affect health care decisions for this patient, so some would argue they don’t belong in the patient’s
chart. Instead, an analysis of the case should be given to the involved staff (both at the hospital and the Organ
Procurement Organization).
In addition, the ethics consultant(s) should follow up on the policy issue of whether pregnancy testing should be
established as a standard procedure pre-organ procurement if not already done in the clinical setting. This case
clearly has implications beyond the question posed to the consultant: “Can we test the patient for pregnancy without consent?”
Anita Tarzian, PhD, RN
Co-Editor
MHECN Program Coordinator
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clear lower limit to the gestational
age which would restrict the physician's efforts to support the brain-dead
mother and her fetus.” There is still the
potential for the mother’s organ/tissue
donation to occur after childbirth.
If the results are not pregnancy, but
rather cancer, one could argue that
the next of kin should be told of those
results if there is the potential for that
type of cancer to be genetic (i.e., other
family members might also need to be
tested).
As always, there is an ethical duty
to recognize that scope of practice issues apply. Due to the complexity and
time sensitivity of this case, it should
be handled by a professional medical
ethicist rather than a hospital ethics
committee (the latter group will likely
not be prepared to handle it unless

it is staffed with an on-call medical
ethicist).
Katrina A. Bramstedt, PhD
Clinical Ethicist
Associate Professor
Bond University School
of Medicine
Queensland, Australia
www.AskTheEthicist.com
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CALENDAR OF EVENTS
OCTOBER
1
The Role of Patient Satisfaction: What Does it Mean for Health Care? The New York Academy of Medicine, 1216 Fifth
Avenue at 103rd Street, New York, NY. For more information, visit http://www.nyam.org/events/2012/2012-10-01.html .
10 (2-5P)
Albert R. Jonsen Bioethics Symposium: The Journey of Bioethics: Past, Present, and Future. A Roundtable with Prominent
Figures in Bioethics. The City Club, 155 Sansome Street, San Francisco, CA. For more information, visit: http://www.
cpmc.org/services/ethics/events.html
11-12
The 10th Annual Conference on Contemporary Catholic Healthcare Ethics End of Life Care & Institutional Identity in the
Catholic Tradition. Loyola University Chicago Stritch School of Medicine, Maywood, Illinois. For more information, visit:
http://bioethics.lumc.edu/news_and_events/CHA_2012.html
11-12
International Neuroethics Conference, sponsored by the International Neuroethics Society. New Orleans Marriot, New
Orleans, LA. For more information, visit: http://www.neuroethicssociety.org/2012-annual-meeting
18-21
“Representing Bioethics:” Annual Meeting of the American Society for Bioethics and Humanities. Hyatt Regency on Capitol Hill, Washington, DC. For more information, visit http://www.asbh.org.
24 (4-6P)
Politics of Assistive Technology: The Case of 20th Century Reading Machines. Speaker: Mara Mills, Ph.D., Assistant Professor, Media, Culture & Communication, New York University. Sponsored by Penn Center for Bioethics. 3401 Market St,
Suite 321, Philadelphia, PA. For more information, visit: http://www.bioethics.upenn.edu/Colloquium.shtml
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23-25
Brain Matters 3 “Values at the Crossroads of Neurology, Psychiatry & Psychology.” Marriott Cleveland Downtown at Key
Center, Cleveland, OH. For more information, visit: http://www.clevelandclinicmeded.com/live/courses/2012/epilepsy12/
agenda.htm

NOVEMBER
1
Reproductive Justice: The New Constitutional Battle Front. Stuart Rome Lecture at the University of Maryland King Carey
School of Law. Ceremonial Moot Court Room, 500 West Baltimore Street, Baltimore, MD. For more information, visit:
http://www.law.umaryland.edu/calendar/
2
Institutional Financial Conflicts of Interest in Research Universities. Wasserstein, Milstein Conference Rooms, Harvard
Law School, Cambridge, MA. For more information, visit: http://http://www.law.harvard.edu/programs/petrie-flom/events/
conferences/fcoi/index.html
2-5
Clinical Ethics Immersion, sponsored by the Center for Ethics at Washington Hospital Center, MedStar Washington Hospital Center, Washington, D.C. For more information, visit: whcenter.org/ethics
9
AMBI Clinical Ethics Conference. Albany Medical College, Albany, NY. For more information, visit: http://www.amc.edu/
Academic/CME/Upcoming_Events.cfm

DECEMBER
13 (4-6P)
The Body Politic: The Battle Over Science in America. Penn Center for Bioethics Conversation Series featuring Jonathan
Moreno, PhD (book author) and Arthur Caplan, PhD. Sponsored by Penn Center for Bioethics. 3401 Market St, Suite 321,
Philadelphia, PA. For more information, visit: http://www.bioethics.upenn.edu/Colloquium.shtml.
JANUARY
10 (4-6P)
What do we do about low-value medical services? Speaker: Ezekiel J. Emanuel, M.D., Ph.D., University of Pennsylvania.
Sponsored by Penn Center for Bioethics. 3401 Market St, Suite 321, Philadelphia, PA. For more information, visit: http://
www.bioethics.upenn.edu/Colloquium.shtml
FEBRUARY
1
5th Annual Medicine and the Humanities and Social Sciences Conference, Sam Houston State University College of Humanities and Social Science, Huntsville, TX. For more information, visit: http://www.shsu.edu/~hss001/conference/
15 (4-6P)
Upcoming revolution in prenatal testing. Speaker: Vardit Ravitsky, Ph.D., Bioethics Program, University of Montreal.
Sponsored by Penn Center for Bioethics. 3401 Market St, Suite 321, Philadelphia, PA. For more information, visit: http://
www.bioethics.upenn.edu/Colloquium.shtml

More than 200 people attended (and over 500 viewed the live webcast) of the July 27-28, 2012
conference, The Thin Ethical Line: When Professional Boundaries and Personal Interests Collide,
sponsored by the Treuman Katz Center for Pediatric bioethics at Seattle Children’s Hospital. Free
webcasts are available at www.seattlechildrens.org/bioethics.
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